We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Six Factors That Influence REMS Decisionmaking Outlined in Draft Guidance
Six Factors That Influence REMS Decisionmaking Outlined in Draft Guidance
The FDA will decide whether to require a Risk Mitigation and Evaluation Strategy after weighing known and potential adverse events, the seriousness of the condition, and the drug’s expected benefits, according to a draft guidance to industry.